IVBH Information

IVBH is a creative-technical studio that turns biological discovery into products, companies, and new possibilities for human health. We are the studio behind Mammogen, LiquidLung, and HepGene — franchises spanning women’s health, lung health, and metabolic health, pioneering high-performance blood tests designed to detect breast cancer, lung cancer, and MASH in the earliest stages of disease. Our studio brings together computational biology, translational science, and company-building to move promising biological insights through product development and clinical validation, then into focused companies purpose-built to share our innovations with the world. Because discovery shouldn’t end in a computer, a lab, or a publication. It should become a real product, solving a real problem, for real people, in a real market. For us, the prize is never just the discovery. It’s what the discovery makes possible. Earlier insight. Better choices. More time. Before disease shouts, biology whispers. We’re building the tools to listen.